BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 22081350)

  • 1. Mass spectrometry-based biomarker discovery.
    Zhou W; Petricoin EF; Longo C
    Methods Mol Biol; 2012; 823():251-64. PubMed ID: 22081350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mass Spectrometry-Based Biomarker Discovery.
    Zhou W; Petricoin EF; Longo C
    Methods Mol Biol; 2017; 1606():297-311. PubMed ID: 28502008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global and targeted quantitative proteomics for biomarker discovery.
    Veenstra TD
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):3-11. PubMed ID: 17023222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in computational analysis of mass spectrometry for proteomic profiling.
    Sun CS; Markey MK
    J Mass Spectrom; 2011 May; 46(5):443-56. PubMed ID: 21500303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein mass spectra data analysis for clinical biomarker discovery: a global review.
    Roy P; Truntzer C; Maucort-Boulch D; Jouve T; Molinari N
    Brief Bioinform; 2011 Mar; 12(2):176-86. PubMed ID: 20534688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Capillary electrophoresis coupled to mass spectrometry for proteomic profiling of human urine and biomarker discovery.
    Zürbig P; Schiffer E; Mischak H
    Methods Mol Biol; 2009; 564():105-21. PubMed ID: 19544019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitation of heat-shock proteins in clinical samples using mass spectrometry.
    Kaur P; Asea A
    Methods Mol Biol; 2011; 787():165-88. PubMed ID: 21898236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted proteomics by selected reaction monitoring mass spectrometry: applications to systems biology and biomarker discovery.
    Elschenbroich S; Kislinger T
    Mol Biosyst; 2011 Feb; 7(2):292-303. PubMed ID: 20976349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical proteomics: liquid chromatography-mass spectrometry purification systems.
    Henry M; Meleady P
    Methods Mol Biol; 2011; 681():473-83. PubMed ID: 20978984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical perspectives of high-resolution mass spectrometry-based proteomics in neuroscience: exemplified in amyotrophic lateral sclerosis biomarker discovery research.
    Ekegren T; Hanrieder J; Bergquist J
    J Mass Spectrom; 2008 May; 43(5):559-71. PubMed ID: 18416436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarker discovery for kidney diseases by mass spectrometry.
    Niwa T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul; 870(2):148-53. PubMed ID: 18024247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alignment of LC-MS images, with applications to biomarker discovery and protein identification.
    Vandenbogaert M; Li-Thiao-Té S; Kaltenbach HM; Zhang R; Aittokallio T; Schwikowski B
    Proteomics; 2008 Feb; 8(4):650-72. PubMed ID: 18297649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sample preparation and fractionation for proteome analysis and cancer biomarker discovery by mass spectrometry.
    Ahmed FE
    J Sep Sci; 2009 Mar; 32(5-6):771-98. PubMed ID: 19219839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CE-MS in biomarker discovery, validation, and clinical application.
    Mischak H; Schanstra JP
    Proteomics Clin Appl; 2011 Feb; 5(1-2):9-23. PubMed ID: 21280234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mass spectrometry-coupled techniques for viral-related disease biomarker identification.
    Rhea JM; Diwan CA; Molinaro RJ
    Biomark Med; 2010 Dec; 4(6):859-70. PubMed ID: 21133707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarker discovery from the plasma proteome using multidimensional fractionation proteomics.
    Lee HJ; Lee EY; Kwon MS; Paik YK
    Curr Opin Chem Biol; 2006 Feb; 10(1):42-9. PubMed ID: 16418010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in capillary electrophoresis-based proteomic techniques for biomarker discovery.
    Fang X; Balgley BM; Lee CS
    Electrophoresis; 2009 Dec; 30(23):3998-4007. PubMed ID: 19960464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary proteomics based on capillary electrophoresis-coupled mass spectrometry in kidney disease: discovery and validation of biomarkers, and clinical application.
    Mischak H; Delles C; Klein J; Schanstra JP
    Adv Chronic Kidney Dis; 2010 Nov; 17(6):493-506. PubMed ID: 21044772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of regulatory molecular events and biomarkers using 2D capillary chromatography and mass spectrometry.
    Powell DW; Merchant ML; Link AJ
    Expert Rev Proteomics; 2006 Feb; 3(1):63-74. PubMed ID: 16445351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma-derived microparticles for biomarker discovery.
    Smalley DM; Ley K
    Clin Lab; 2008; 54(3-4):67-79. PubMed ID: 18630736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.